dexamethasone,daratumumab,bortezomib,lenalidomide
takeda,janssen
['griffin', 'multiplemyeloma', 'janssen']
for us #hcps attending #ash22, see dr. rebecca silbermann as she presents patient reported outcomes from the phase 2 griffin study of transplant-eligible patients with newly diagnosed #multiplemyeloma.
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.